Addressing anxiety in patients undergoing active surveillance for low-risk cancers

Patients with low-risk cancers undergoing active surveillance face a favorable long-term prognosis. David Haggstrom, M.D., MAS, makes the case that it's time for the medical field to help manage the anxiety caused by waiting.

Dr. Haggstrom, a physician-researcher with Regenstrief Institute, the Veterans Administration Medical Center in Indianapolis and the Indiana University School of Medicine, is lead author of a Viewpoint article, published in JAMA (Journal of the American Medical Association) Oncology, presenting the case for interventions designed to reduce the anxiety related to cancer monitoring.

Medical research increasingly shows that observation – known as active surveillance – can be a reasonable approach to monitoring low-risk cancers in cases where treatment confers little or no benefit. While this strategy can avoid unnecessary interventions, it can also create significant anxiety for patients.

"Cancer elicits fear, regardless of the disease's severity. While observation is appropriate for certain types of cancer, like early prostate or thyroid cancer, the problem of uncertainty and stress remains after being labeled with a cancer diagnosis. There is even a name for the anxiety around the time of a follow-up medical test, called scanxiety."

No amount of information about the prognosis of a low-risk cancer can eliminate uncertainty, which can produce a variety of negative responses, including perceptions of vulnerability, feelings of fear and a propensity to avoid decision-making. Dr. Haggstrom suggests several potential interventions for consideration.

  • Cognitive behavioral therapy
  • Acceptance and commitment therapy
  • Mindfulness meditation programs
  • Patient decision aids
  • Clinical decision support tools

In addition to testing interventions, future research should focus on understanding how uncertainty leads to anxiety. Long-term studies are needed to track how patient responses to uncertainty change over time, especially given the extended lifespans of many patients under observation.

Healthcare should be patient-centered and account for any distress among patients caused by the tests they receive. While surveillance intervals may be long, once a cancer diagnosis is made, patients still live with that knowledge every day."

Dr. David Haggstrom, M.D., MAS, physician-researcher with Regenstrief Institute

Source:
Journal reference:

Haggstrom, D. A., et al. (2024). Active Surveillance for Low-Risk Cancer—The Waiting Is the Hardest Part. JAMA Oncologydoi.org/10.1001/jamaoncol.2024.2667.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers question the use of "cancer" for certain prostate conditions